Financial Data and Key Metrics Changes - Consolidated net sales increased by 1.4% year-over-year to 457million,withforeignexchangereducingreportednetsalesbyapproximately440basispoints[33]−Adjustedgrossmarginwas19.435.4 million, down from 68.1millionintheprioryear[37]BusinessLineDataandKeyMetricsChanges−NorthAmericansalesgrewby1719 million in Q4, with a full-year operating cash flow of 80million[47]−Thecompanyrepurchased0.5millionsharesatanaveragepriceof26.13 per share, totaling approximately $13 million [50] - The leverage ratio was 3.9x as of June 30, 2022, near the top end of the stated range [60] Q&A Session Summary Question: Why was the guidance range widened for fiscal '23? - Management indicated that the widening of the range reflects the volatile environment in Europe and the challenges in forecasting [71] Question: What is the outlook for plant-based products in Europe? - Management noted that the plant-based beverage category has seen a decline, but they remain confident in the long-term trajectory of the category [73] Question: What is the company's approach to pricing in fiscal '23? - Management clarified that they are covering visible inflation with pricing and are prepared to take further pricing actions if necessary [80] Question: How is the company addressing supply chain issues? - Management stated that most supply chain disruptions are expected to be resolved by the end of Q1, with a focus on improving productivity [93] Question: What are the expectations for marketing spend in fiscal '23? - Management indicated that marketing investments will be modest due to inflation pressures, but they remain committed to supporting brand growth [89] Question: What is the company's strategy regarding plant-based capacity expansion? - Management confirmed that they are not expanding capacity in plant-based products at this time, pending a clearer outlook for the category [92]